linjc16/ctgov huggingface dataset:
An Observational, Epidemiological Study on the Prevalence of Human Papillomavirus Types in Women in Egypt

Study Overview
=================
Brief Summary
-----------------
The purpose of the study is to determine the Human Papillomavirus (HPV) prevalence and HPV type distribution among women aged >= 18 years, attending out-patient health services for gynaecological examination and who agree to HPV testing in Egypt .

Official Title
-----------------
An Observational, Epidemiological Study on the Prevalence of Human Papillomavirus (HPV) Types in Women >= 18 Years of Age, in Egypt

Conditions
-----------------
Human Papillomavirus Infection

Intervention / Treatment
-----------------
* Procedure: Endocervical samples


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Women >= 18 years of age attending a clinic for gynaecological examination. Women who agree to provide a cervical sample for human papillomavirus testing. Written informed consent obtained from the subject. Exclusion Criteria: Referral for abnormal cervical sample at the current visit. Abundant menstrual bleeding or vaginal discharge not allowing appropriate screening to be performed. History of hysterectomy. Known diagnosis of immunosuppression, or patient on immunosuppressives. Pregnant women. Having received one or more doses of HPV vaccine prior to participating in the study.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Assessed cohort<br>Subjects attending out-patient health services for gynaecological examination. | Procedure: Endocervical samples<br>* Endocervical samples collection during routine gynaecological examinations.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Occurrence of Human papillomavirus (HPV) DNA and of any of the HPV types among women undergoing cervical sample testing. |  | Average timeframe: 12 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Occurrence of HPV DNA and of any of the HPV types among women of different age-strata undergoing cervical sample testing |  | Average timeframe: 12 months | 
| Behavioural risk factors assessed by behavioral questionnaire |  | At the single study visit (Day 0) | 
| Assessing the awareness of HPV in relation to transmission and cause of cervical cancer |  | At the single study visit (Day 0) |
Socio-economic, Meteorological and Environmental Factors Associated With the Incidence of COVID-19

Study Overview
=================
Brief Summary
-----------------
Socio-demographic factors in relation to the diagnosis of COVID cases are increasingly mentioned in the role of transmission, but unfortunately with a small number of conclusive publications on French data. Our objective is to analyse the distribution of cases according to these factors and their possible role during the first 6 weeks of 2021 when the Alpes Maritimes was the department with the highest incidence rate. The collaboration between ARS06 and the Public Health Department in the field of COVID-19 has made it possible to have a departmental bulletin for monitoring the evolution of the epidemic (incidence, screening, hospitalisation). Knowledge of the socio-demographic, meteorological and environmental factors associated with the transmission of SARS-CoV2 would make it possible to reflect on how to act on these factors and to implement a public health policy.

Official Title
-----------------
Socio-economic, Meteorological and Environmental Factors Associated With the Incidence of COVID-19 in the Alpes-Maritimes and the City of Nice

Conditions
-----------------
COVID-19

Intervention / Treatment
-----------------
* Other: COVID-19 infection


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Any person, adult or not, residing in the Alpes-Maritimes between 03/01/2021 and 14/02/2021 with a COVID-19 diagnosis. Exclusion Criteria: Non resident in the Alpes-Maritimes

Ages Eligible for Study
-----------------
Minimum Age: 0 Years
Maximum Age: 120 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Other: COVID-19 infection|All persons of legal age or not resident in the Alpes-Maritimes between 03/01/2021 and 14/02/2021 with a COVID-19 diagnosis.|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Weekly incidence rate of COVID-19 in the Alpes-Maritimes during the study period. | Weekly incidence rate in the Alpes Maritimes according to the age group, by district of Nice and town | Between 03/01/2021 and 14/02/2021 | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Weekly incidence rate of COVID-19 in the Alpes-Maritimes during the study period according to participants' social and economic factors | Weekly incidence rate by social disadvantage index and others socioeconomic indicators by Census block of Nice, correlation analyses | Between 03/01/2021 and 14/02/2021 | 
| Weekly incidence rate of COVID-19 in the Alpes-Maritimes during the study period according to climatic factors | Correlation of incidence rates with temperature, humidity, concentrations in air pollutants (fine particles, nitrogen oxides) | Between 03/01/2021 and 14/02/2021 |
Factors Related to the Progression of Chronic Kidney Disease

Study Overview
=================
Brief Summary
-----------------
Chronic kidney disease is a progressive disorder that has been influenced with many factors. Most of the patients has altered Ca P metabolism and these dis orders are the contributing factors of the disease progression. It has been recently documented that FGF23 and Klotho are the key factors of PTH secretion Ca-P metabolism. This study aimed to evaluate the impact of Klotho and FGF23 on the progression of stage 3-4 chronic kidney disease.

Official Title
-----------------
The Impact of FGF23 and Klotho on Progression of Chronic Kidney Disease

Conditions
-----------------
Chronic Kidney Disease

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Non-diabetic chronic kidney disease Exclusion Criteria: Presence of DM Actively using calcium based phosphorus binder of vitamin D

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 65 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Progressive disease<br>Serum creatinin level rise more than 2 times | |
| Non-progressive disease<br>Serum creatinin level rise less than 2 times | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Progression of kidney disease | Doubling of creatinin, requirement of renal replacement therapy | continuous measurement of kidney functions 3 monthly for two years or until the outcome reached | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Evaluation of Ca P metabolism | Determination of Ca-P metabolism disorders. | 3 monthly for two years or until the outcome reached | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Chronic kidney disease progression, FGF 23, Klotho
Care Transitions in Renal Disease Patients

Study Overview
=================
Brief Summary
-----------------
The goal of this pilot is to reduce the 30-day hospital readmission rate for dialysis patients. It is a quality improvement project that consistent of 4 tracks. Tracks 1 & 2: Implement use of checklists of activities for staff to complete when patients are admitted to the hospital, and post-hospitalization with emphasis on fluid assessment, nutrition management, patient coaching, and communication between institutions. Track 3: Work with physicians to develop process to individualize post-hospitalization dialysis orders and improve medication reconciliation. Track 4: Use a renal Care Transitions Case Manager to follow patients in the hospital and 30 days post-hospitalization to facilitate care and patient coaching.

Official Title
-----------------
Care Transitions in Renal Disease Patients

Conditions
-----------------
Renal Disease

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Chronic hemodialysis patients All patients admitted to the hospital during the study period Exclusion Criteria: Patients <18 years old

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| 30-day readmission rate | Number of hospitalizations that occur within 30 days after discharge from an initial index hospitalization (convert to percentage of 30-day readmissions). | Participants will be followed for the duration of each hospital stay and 30 days post-hospitalization, for an expected average of 37 days. |
Shoulder Profile Among Swimmers and Badminton Players

Study Overview
=================
Brief Summary
-----------------
Background: To compare the pre-season clinical measures with shoulder rotator strength and range of motion between bilateral (swimmers) and unilateral (badminton players) overhead athletes. Design: Prospective cohort study Participants: 42 athletes were enrolled including 24 elite badminton players and 18 elite swimmers Independent variables: A pre-season visit consisted in clinical and isokinetic shoulder strength testing. Clinical testing consisted in the shoulder range of motion (ROM) measurements aIsokinetic internal and external rotator shoulder muscles strength was tested at 60. Conventional and functional (eccentric-to-concentric) ratios (FR) were calculated.

Official Title
-----------------
A Comparative Study on Shoulder Rotational Strength and Range of Motion Between Unilateral and Bilateral Overhead Elite Athletes

Conditions
-----------------
Sport Injury, Shoulder Injuries

Intervention / Treatment
-----------------
* Other: Shoulder clinical testing with isokinetic strength assessment


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: All the elite badminton players from a high-level club and the National Institute of Sport, Expertise, and Performance All the elite swimmers a high-level club Exclusion Criteria: Players who had SSI in the 3 months prior to the isokinetic test or had shoulder surgery
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Other: Shoulder clinical testing with isokinetic strength assessment|All the participants had a shoulder clinical testing including shoulder rotators range of motion and isokinetic rotator muscle strength testing|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Baseline Isokinetic strength testing (peak torques) | Shoulder rotator muscles isokinetic strength test, Measures: Peak Torque on internal rotator muscles (IR) and external rotator muscles (ER), in NM (newton.meter) | one preseason evaluation (september 2017 or september 2018 or september 2019) | 
| Baseline Isokinetic strength testing (ratios) | Shoulder rotator muscles isokinetic strength test, Measures: ratios between external rotator muscles (ER) and internal rotator muscles (IR) (ER:IR), in percent (%) | one preseason evaluation (september 2017 or september 2018 or september 2019) | 
| Clinical measurements, ROM | Shoulder internal and external rotation range of motion (ROM) | one preseason evaluation (september 2017 or september 2018 or september 2019) |
A Study of Avastin in Combination With Chemotherapy for Treatment of Colorectal Cancer and Non-Small Cell Lung Cancer (ARIES)

Study Overview
=================
Brief Summary
-----------------
This is an observational study designed to follow patients with metastatic or locally advanced and unresectable CRC or locally advanced or metastatic NSCLC (excluding predominant squamous histology) who are receiving Avastin in combination with first-line chemotherapy. Second-line metastatic CRC patients are also eligible. Patients who started their Avastin containing therapy <4 months prior to enrollment are eligible.

Official Title
-----------------
An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy for Treatment of Metastatic or Locally Advanced and Unresectable Colorectal Cancer and Locally Advanced or Metastatic Non-Small Cell Lung Cancer (Excluding Predominant Squamous Cell Histology)

Conditions
-----------------
Colorectal Cancer, Non-Small Cell Lung Cancer

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Signed Informed Consent Form Metastatic or locally advanced and unresectable CRC or locally advanced or metastatic NSCLC (excluding predominant squamous histology) Eligible for Avastin as a component of intended therapy First-line chemotherapy (or second-line chemotherapy for CRC) plus Avastin initiated ≤ 4 months prior to study enrollment Exclusion Criteria: Any medical condition, including mental illness or substance abuse, deemed by the investigator to be likely to interfere with a patient's ability to provide informed consent or comply with the treatment and follow-up, as specified by the investigator Enrollment in a blinded, placebo-controlled bevacizumab trial
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
NSCLC, Avastin, anti-VEGF, lung cancer, colorectal cancer, ARIES, Colon Cancer
Using Isosorbide Mononitrate in Reducing Time in Induction of Labor in Post Date Women

Study Overview
=================
Brief Summary
-----------------
We will compare between using isosorbide mononitrate together with misoprostol versus the misoprostol alone in induction of labor in postdate women

Official Title
-----------------
Efficacy of Intravaginal Administration of Isosorbide Mononitrate Together With Misoprostol Versus Misoprostol Alone in Induction of Labor in Postdate Women

Conditions
-----------------
Induction of Labor

Intervention / Treatment
-----------------
* Drug: Isosorbide mononitrate
* Drug: Misoprostol


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: age (20-35 yrs) single fetus gestational age > 40weeks not in labor bishop score < 7 no medical disorder Exclusion Criteria: Gestational age ≤40 weeks patient with a ripe cervix rupture of membranes suspected chorioamnionitis placenta previa history of major uterine surgery hypertonic uterine pattern contraindicated to receive PG fetal malpresentation multiple pregnancy intrauterine growth retardation women with any general medical disorder

Ages Eligible for Study
-----------------
Minimum Age: 20 Years
Maximum Age: 35 Years

Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Sham Comparator: Misoprostol alone<br>Enrolled women will receive 25 πg of misoprostol which will be placed intravaginally 4 hourly, maximum up to 5 doses | Drug: Misoprostol<br>* Used intravaginally to ripe the cevix in induction of labor<br>|
| Active Comparator: Isosorbide mononitrate with misoprostol<br>Enrolled women will receive 25 πg of misoprostol together with 40 mg isosorbide mononitrate which will be placed intravaginally 4 hourly, maximum up to 5 doses | Drug: Isosorbide mononitrate<br>* Administration of isosorbide mononitrate vaginaly together with misoprostol in induction of labor in postdate women<br>Drug: Misoprostol<br>* Used intravaginally to ripe the cevix in induction of labor<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| The duration of induction to active phase interval | Measure the time between the beginning of the induction to enter the active phase of labor | 12 weeks |
Health-Related Quality of Life in Upper Secondary Schools in Denmark

Study Overview
=================
Brief Summary
-----------------
Measuring Quality of Life in an upper secondary school in Denmark

Detailed Description
-----------------
The Child Health Utility 9 Dimension (CHU9D) is a relatively new health-related quality of life (HRQoL) instrument for use in children and young people. CHU9D has recently been translated and linguistic validated into Danish. The objective of this study is twofold. Firstly, the investigators wants to examine the feasibility of using the Danish version of CHU9D to assess the HRQoL in young adults. Secondly, the investigators wants to analyse the association of wellbeing, happiness with the school and the learning environment with the students HRQoL in the Northern Danish Region of Denmark.

Official Title
-----------------
(Danish): Sundhed, Trivsel og Læring på HHX og HTX, Erhvervsskolerne i Aars

Conditions
-----------------
Quality of Life

Intervention / Treatment
-----------------
* Other: A questionnaire; CHU9D


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Students at the Higher Commercial Examination (HHX) and Higher Technical Examination (HTX) at the Technical College in Aars. Exclusion Criteria: There will be no exclusion criteria concerning diseases or conditions for these school students.

Ages Eligible for Study
-----------------
Minimum Age: 15 Years
Maximum Age: 22 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Other: A questionnaire; CHU9D|Measuring Health Related Quality of Life|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| QALY | Quality Adjusted Life Years | 3-5 years | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Mental Health, Physical Health
A Preliminary Study Utilizing a Flexible Endoscope for Pelvic Culdoscopy

Study Overview
=================
Brief Summary
-----------------
The culdoscopic approach will allow for equal or better visualization of female pelvic structures

Official Title
-----------------
A Preliminary Study Utilizing a Flexible Endoscope for Pelvic Culdoscopy

Conditions
-----------------
Diagnostic or Therapeutic Laparoscopy

Intervention / Treatment
-----------------
* Device: Flexible Endoscope


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Female Ages 18 to 70 years old Ability to understand and give informed consent Scheduled for diagnostic or therapeutic laparoscopy for a clinical indication Presence of a uterus and at least one ovary at the initiation of the procedure Exclusion Criteria: Documented culdesac mass Inability to tolerate anesthesia Documentation of positive urine pregnancy test History of prior pelvic radiation Scheduled for emergency laparoscopy Any other medical or psychiatric condition that, in the opinion of the investigative team, will interfere with the ability of the participant to safely complete the study History of significant non-compliance with previous therapy or unwillingness to return for follow up visits Prior hysterectomy and/or bilateral salpingo-oophorectomy

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 70 Years

Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Group 1 - Device<br>The principal Investigator and sub-investigators of this study will identify potential participants that attend the gynecologic oncology or gynecology clinics of UAMS. These subjects will have been scheduled for diagnostic or therapeutic laparoscopy. Based on the Inclusion Criteria and Exclusion Criteria of this study, women who are eligible for the study will be approached to participate. | Device: Flexible Endoscope<br> <br> |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Visualization of female pelvic structures using a flexible endoscope and a standard laparoscope will be compared. |  | 02/2010 | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Complications related to the procedures will be recorded and, if possible, attributed to one of the two techniques. If feasible, a comparison will be made between complications attributable to each approach. |  | 02/2010 |
Educational Materials for Hiccups

Study Overview
=================
Brief Summary
-----------------
This is a research study about hiccup educational materials. The purpose of this study is to learn whether this type of research can be done.

Official Title
-----------------
A Feasibility Double-Blinded, Randomized Study of Educational Materials for Hiccups

Conditions
-----------------
Hiccup

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Age ≥ 18 years of age. Hiccups in the 4 weeks prior to phone contact (patient must confirm). Able to speak and read English. Has an e-mail address. Exclusion Criteria: - Individuals < 18 years of age.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Mayo Clinic hiccup educational materials<br> | |
| Mayo Clinic hiccup educational materials + updated supplementary content<br> | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Feasibility of enrollment | This is a feasibility study that seeks to enroll 20 patients with hiccups in 5 months from the start of trial recruitment. | 5 months |